An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes

Pediatric Blood and Cancer

Volumn 65, Issue 1, 2018, Pages

  Bou Maroun, Laura M ^a   Meta, Fabien ^b   Hanba, Curtis J ^b   Campbell, Andrew D ^c   Yanik, Gregory A ^c  

^a Children's Hospital of Michigan   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

acute chest syndrome; cerebrovascular accident; hospitalization costs; kids inpatient database; sickle cell disease; splenic sequestration; vaso occlusive crisis

Indexed keywords

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE BURDEN; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INCIDENCE; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OUTCOME ASSESSMENT; PEDIATRICS; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; SPLEEN DISEASE; SPLENIC SEQUESTRATION; TRANSIENT ISCHEMIC ATTACK; VASOOCCLUSIVE PAIN CRISIS; AGE; COST; ECONOMICS; FACTUAL DATABASE; INFANT; MORTALITY; NEWBORN;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE;

EID: 85034958191     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26758     Document Type: Article

References (31)

1. Bunn HF, Aster J. Pathophysiology of blood disorders. New York: McGraw-Hill; 2011.
2. CDC. Sickle cell disease data & statistics. 2016. http://www.cdc.gov/ncbddd/sicklecell/data.html.
3. Hoppe CC. Newborn screening for hemoglobin disorders. Hemoglobin. 2011;35(5–6):556–564.
4. Gavini N, Hoots WK, Mensah GA, Hanspal M. An analysis of the NIH-supported sickle cell disease research portfolio. Blood Cells Mol Dis. 2015;54(2):198–205.
5. Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288–1294.
6. Ellison AM, Bauchner H. Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease. J Natl Med Assoc. 2007;99(3):192–196.
7. Panepinto JA, Brousseau DC, Hillery CA, Scott JP. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer. 2005;44(2):182–186.
8. Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–69.
9. Roberts I, de Montalembert M. Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe. Haematologica. 2007;92(7):865–871.
10. Wang Y, Kennedy J, Caggana M, et al. Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med. 2013;15(3):222–228.
11. AHRQ. HCUP databases: KID overview. 2016. https://www.hcup-us.ahrq.gov/kidoverview.jsp.
12. Bekelis K, Connolly ID, Do HM, Choudhri O. Operative volume and outcomes of cerebrovascular neurosurgery in children. J Neurosurg Pediatr. 2016;18(5):623–628.
13. Hanba C, Bobian M, Svider PF, et al. Perioperative considerations and complications in pediatric parathyroidectomy. Int J Pediatr Otorhinolaryngol. 2016;91:94–99.
14. Hanba C, Svider PF, Shkoukani MA, et al. Pediatric pituitary resection: characterizing surgical approaches and complications. Int Forum Allergy Rhinol. 2017;7:72–79.
15. Benson JM, Therrell BL, Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010;34(2):134–144.
16. DeBaun MR, Strunk RC. The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia. Lancet. 2016;387(10037):2545–2553.
17. Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14(3):168–174.
18. Haywood C, Jr., Tanabe P, Naik R, Beach MC, Lanzkron S. The impact of race and disease on sickle cell patient wait times in the emergency department. Am J Emerg Med. 2013;31(4):651–656.
19. Brousse V, Elie C, Benkerrou M, et al. Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol. 2012;156(5):643–648.
20. Brown AK, Sleeper LA, Miller ST, Pegelow CH, Gill FM, Waclawiw MA. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med. 1994;148(8):796–804.
21. Topley JM, Rogers DW, Stevens MC, Serjeant GR. Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease. Arch Dis Child. 1981;56(10):765–769.
22. Owusu-Ofori S, Remmington T. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database Syst Rev. 2015(9):CD003425.
23. Cherry MG, Greenhalgh J, Osipenko L, et al. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Health Technol Assess. 2012;16(43):1–129.
24. Cunningham-Myrie C, Abdulkadri A, Waugh A, et al. Hydroxyurea use in prevention of stroke recurrence in children with sickle cell disease in a developing country: a cost effectiveness analysis. Pediatr Blood Cancer. 2015;62(10):1862–1864.
25. Ware RE, Davis BR, Schultz WH, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016;387(10019):661–670.
26. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294.
27. Schatz J. Brief report: academic attainment in children with sickle cell disease. J Pediatr Psychol. 2004;29(8):627–633.
28. Smeltzer MP, Nolan VG, Yu X, et al. Distance from an urban sickle cell center and its effects on routine healthcare management and rates of hospitalization. Hemoglobin. 2016;40(1):10–15.
29. Kressin NR, Chang BH, Hendricks A, Kazis LE. Agreement between administrative data and patients' self-reports of race/ethnicity. Am J Public Health. 2003;93(10):1734–1739.
30. Zingmond DS, Parikh P, Louie R, et al. Improving hospital reporting of patient race and ethnicity–approaches to data auditing. Health Serv Res. 2015;50(Suppl 1):1372–1389.
31. Wolfson JA, Schrager SM, Coates TD, Kipke MD. Sickle-cell disease in California: a population-based description of emergency department utilization. Pediatr Blood Cancer. 2011;56(3):413–419.